KYTX
Kyverna Therapeutics, Inc.
+0.15 (+2.17%)7.05USD206K成交股數436M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 24.8M | 30.1M | 30.0M | 30.5M | 35.8M | 37.4M | 29.2M | 27.3M | 22.5M | 17.2M | 13.6M | 10.4M |
| 銷售管理費用 | 14.8M | 11.3M | 9.3M | 8.3M | 8.6M | 10.0M | 9.6M | 6.1M | 6.9M | 4.2M | 2.6M | 2.9M |
| 營業利益 | −39.6M-11% | −41.4M-13% | −39.3M+1% | −38.7M+16% | −44.4M+51% | −47.4M+122% | −38.8M+138% | −33.4M+151% | −29.4M | −21.4M | −16.3M | −13.3M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −38.3M-9% | −39.7M-11% | −37.8M+10% | −36.8M+28% | −42.1M+58% | −44.6M+116% | −34.5M+123% | −28.8M+120% | −26.7M | −20.7M | −15.5M | −13.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.63-35% | -0.66-36% | -0.79-1% | -0.85+27% | -0.97-13% | -1.03-97% | -0.80-97% | -0.67-97% | -1.12 | -33.38 | -23.27 | -20.86 |
| 稀釋股數 | 60.9M | 60.4M | 44.3M | 43.4M | 43.2M | 43.2M | 43.2M | 43.1M | 23.8M | 674K | 665K | 628K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 31.8M | 32.2M | 124M | 34.2M | 53.4M | 56.9M | 105M | 132M | 224M | 34.6M | 23.0M | 53.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 220M | 257M | 294M | 187M | 227M | 261M | 339M | 363M | 390M | 75.2M | – | – |
| 有息負債 | 24.9M | – | 24.7M | – | – | – | – | – | – | – | – | – |
| 總負債 | 54.3M | 61.4M | 61.6M | 35.2M | 42.1M | 36.6M | 36.5M | 29.6M | 29.0M | 26.0M | – | – |
| 股東權益 | 166M | 196M | 232M | 152M | 184M | 224M | 303M | 334M | 361M | −13.1M | −112M | −97.2M |
| 負債比 | 24.7% | 23.9% | 20.9% | 18.8% | 18.6% | 14.1% | 10.8% | 8.2% | 7.4% | 34.6% | – | – |
| 淨現金(現金 − 有息負債) | 6.9M | – | 99.4M | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −41.6M-7% | – | – | – | −44.9M | – | – | −25.5M | – | – | – |
| 資本支出 | – | – | – | – | – | 0.00 | – | – | 543K | – | – | – |
| 自由現金流 | – | – | – | – | – | −44.9M | – | – | −26.1M | – | – | – |
| 折舊攤銷 | 300K | 351K | 698K | 300K | 300K | 501K | 300K | 300K | 482K | 913K | 200K | 200K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −161M | –% | -3.64 | −154M |
| FY2024 | – | – | −127M | –% | -3.33 | −116M |
| FY2023 | – | – | −60.4M | –% | -89.61 | −53.0M |